Mabpharm Limited (HKG:2181)

Hong Kong · Delayed Price · Currency is HKD

0.4800

+0.0300 (6.67%)

May 7, 2026, 3:59 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals			87.16M	55.92M	82.88M		14.07M	23.93M
Pharmaceuticals Growth			55.87%	-32.53%	-		-41.18%	410.17%
Total			87.16M	55.92M	82.88M		14.07M	23.93M
Total Growth			55.87%	-32.53%	-		-41.18%	410.17%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
PRC			87.16M	55.92M	82.88M		14.07M	23.93M
PRC Growth			55.87%	-32.53%	-		-41.18%	-
Total			87.16M	55.92M	82.88M		14.07M	23.93M
Total Growth			55.87%	-32.53%	-		-41.18%	-

Source: S&P Global Market Intelligence.